ALLERGIC CONJUNCTIVITIS
Clinical trials for ALLERGIC CONJUNCTIVITIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC CONJUNCTIVITIS trials appear
Sign up with your email to follow new studies for ALLERGIC CONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody shots aim to stop itchy eyes from birch pollen
Symptom relief Recruiting nowThis study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting. The…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New eye drops aim to stop allergy itch and redness
Symptom relief Recruiting nowThis study tests a new eye drop called TL-925 for seasonal allergic conjunctivitis (eye allergies). About 60 adults with a history of eye allergies will receive either the active eye drop or a placebo. Researchers will measure how well it reduces itching and redness after exposur…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE2 • Sponsor: Telios Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Scientists hunt for eye disease clues in your tears
Knowledge-focused Recruiting nowThis study collects tear samples from 300 people with dry eye, infectious keratoconjunctivitis, mucous membrane pemphigoid, or allergic conjunctivitis. Researchers will analyze the proteins and metabolites in tears to create a unique fingerprint for each condition. The goal is to…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC